Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000184

Drug Information
NameOctopamine
Synonymsalpha-(aminomethyl)-4-hydroxybenzenemethanol; LS-42692; Norsympathol; Norden; AKOS000123349; Spectrum_000201; STK801377; SPBio_003077; Prestwick2_000949; SMP1_000221; KBio3_001250; DivK1c_000245; PDSP1_001544; Octopaminum [INN-Latin]; Lopac0_000932; BPBio1_001010; Benzenemethanol, alpha-(aminomethyl)-4-hydroxy-; Benzyl alcohol, alpha-(aminomethyl)-p-hydroxy-; p-Hydroxyphenylethanolamine; NCGC00091918-04; 4-Octopamine; 1-(p-Hydroxyphenyl)-2-aminoethanol; KBio2_005817; NCGC00015760-08; 64C59BC0-9C98-49EF-A853-8849F02ABAAC; beta-hydroxytyramine; KBio1_000245; SDCCGMLS-0066599.P001; Octopamine hydrochloride; p-Norsynephrin; BRN 1211019; Octopaminum [Latin]; 4-(2-Amino-1-hydroxyethyl)phenol; KBioGR_000664; AB00053571; Benzenemethanol, .alpha.-(aminomethyl)-4-hydroxy-; alpha-Aminoethyl-4-hydroxybenzylalkohol; alpha-(Aminoethyl)-4-hydroxybenzenemethanol; Prestwick0_000949; ND 50; IDI1_000245; NINDS_000245; AC1L1IHG; KBio2_003249; Norfen; alpha-(Aminomethyl)-p-hydroxybenzyl alcohol; octopaminum; CID4581; Paraoxyphenyl aminoethanol; Norsynephrine; KBioSS_000681; 4-13-00-02656 (Beilstein Handbook Reference); TBB066518; octopamine; Octopamine [INN]; Prestwick3_000949; PDSP2_001528; p-Octopamine; Spectrum2_000222; EINECS 203-179-5; Octopamina [INN-Spanish]; KBio2_000681; Analet; Octopamin; WIN 5512; BSPBio_001750; NCGC00091918-03; Prestwick1_000949; SPBio_000263; MolPort-002-052-044; Norphen; CHEMBL53929; Spectrum4_000402; WV 569; alpha-(Aminoethyl)-p-hydroxybenzyl alcohol; Spectrum3_000275; Norsympatol; CHEBI:17134; 104-14-3; Spectrum5_001543; UNII-14O50WS8JD; Octopamina [Spanish]; para-Octopamine; Octopamina; BSPBio_000918; Octapamine
CompanySanofi-aventis
IndicationThromboembolic Disorders
[ICD9: 437.6, 453, 671.5, 671.9   ICD10: I80-I82]
Discontinued in Phase IIa    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C8H11NO2/c9-5-8(11)6-1-3-7(10)4-2-6/h1-4,8,10-11H,5,9H2
InChIKeyQHGUCRYDKWKLMG-UHFFFAOYSA-N
Canonical SMILESC1=CC(=CC=C1C(CN)O)O    
CAS NumberCAS 104-14-3
FormulaC8H11NO2
PubChem Compound IDCID 4581.
PubChem Substance IDSID 150781.
SuperDrug ATC IDC01CA18
C01CA18
TargetCoagulation factor XaInhibitor[1][2]
Ref 1Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra-low-molecular-weight heparin, AVE5026. J Thromb Haemost. 2009 Jul;7(7):1143-51. Epub 2009 Apr 27. To Reference
Ref 2AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging study. J Thromb Haemost. 2009 Apr;7(4):566-72. Epub 2009 Jan 24. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543